1. Long-term dienogest treatment in endometriosis: Consensus from Taiwanese experts.
- Author
-
Liu JY, Sheu BC, Chang CY, Yen CF, Wu MH, Chen YJ, Lai TH, Lan KC, Cheng YM, Tsai YC, Law KS, Wu WY, and Chen SN
- Subjects
- Female, Humans, Hormone Antagonists administration & dosage, Hormone Antagonists therapeutic use, Pelvic Pain drug therapy, Pelvic Pain etiology, Taiwan, Consensus, Endometriosis drug therapy, Nandrolone analogs & derivatives, Nandrolone therapeutic use, Nandrolone administration & dosage
- Abstract
Dienogest has been proven effective as long-term therapeutic option for pelvic pain caused by endometriosis. However, in Taiwan, there is a lack of a well-tailored consensus on its long-term administration. To address this gap, Taiwanese experts in collaboration with the Taiwan Endometriosis Society (TES), convened to provide structured recommendations on dienogest treatment and monitoring strategies. Drawing from clinical evidence and collective expertise, the experts formulated individualized treatment strategies based on treatment objectives and the patient's demographics. The experts recommend long-term dienogest administration for endometriosis patients for appropriate symptom control while reducing the risk of disease recurrence. Specifically, they recommend regular ultrasound examinations and relevant blood tests to monitor disease progression and therapeutic response with additional breast screening for patients at high risk for breast cancer. These recommendations aim to provide physicians with comprehensive guidance on the long-term administration of dienogest for endometriosis, ensuring patient safety and optimizing treatment outcomes., Competing Interests: Conflicts of interest The authors declare no conflicts of interest., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF